Innovative Insulin Pumps Drive Optimism for Tandem, Beta Bionics

On Friday, William Blair initiated coverage on Tandem Diabetes Care Inc . (NASDAQ: TNDM ) and Beta Bionics Inc (NASDAQ: BBNX ), noting that both companies are advancing initiatives to play in faster-growing segments of the insulin pump market . Both companies have the potential to benefit from market expansion of pumps into type 2 diabetes (T2D) .

Tandem’s current offerings include the t:slim X2 and the Tandem Mobi, recognized as the smallest durable tubed automated insulin delivery system available. The company shipped its first device in 2012, and its future pipeline features the Mobi Tubeless patch pump, slated for a late-2026 launch following anticipated regulatory ...